Microtubules are cylindrical organelles which play critical roles in mitosis and other cell processes. Because of their role in mitosis, microtubules are the target of taxol, vinblastine and other anti-tumor drugs. Microtubules are composed of the protein tubulin, consisting of two subunits called a and b. Both of these exist in numerous isotypic forms. The different forms of b have been highly conserved in evolution and appear to be functionally different. One of these, bIII , is normally found in neurons and steroili cells, but occurs in elevated amounts in a variety of tumors as well. It also has significantly different interactions with the anti-tumor drugs vinblastine, taxol and colchicine. Part of the reason for the uniqueness of the abIII dimer is the apparent unusual rigidity of its conformation. abIII may be an excellent target for rational drug design, for which it is necessary to determine its three-dimensional structure. However, tubulin is a highly unusual protein in that it has very flexible conformation. The overall aim of this grant is to identify the conformational changes that tubulin undergoes, both spontaneously and in the presence of anti-tumor drugs, to compare these changes in different isotypes and to correlate this information with the effects of drugs on microtubule assembly and dynamics. The first specific aim is to analyze the conformational properties of up to four different isotypes (abI, abIII, abIII, and abIV) using a variety of techniques including probes for sulfhydryl groups and hydrophobic areas. The second specific aim will examine the effects of ligands on these conformational properties; these ligands which have been carefully chosen in that each one has a unique set of interactions with tubulin are colchicine, podophyllotoxin, curacin A, vinblastine, maytansine, phompsin, IK104, griseofulvin, BisANs, taxol, taxotere, GTP, and GDP. In the third specific aim, the specific regions on tubulin affected by these ligands will be identified and located in the known sequence of tubulin. In collaborative studies (fourth specific aim), attempts will be made to furnish the three dimensional structure of tubulin. The results of this study should provide a much clearer understanding of the specific effects of drugs on the tubulin molecule and microtubule dynamics as well as the interactions of tubulin isotypes with anti-tumor drugs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA026376-21
Application #
6137385
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Program Officer
Fu, Yali
Project Start
1979-07-01
Project End
2001-12-31
Budget Start
2000-01-01
Budget End
2001-12-31
Support Year
21
Fiscal Year
2000
Total Cost
$229,233
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Biochemistry
Type
Other Domestic Higher Education
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Vent, Julia; Wyatt, Todd A; Smith, D David et al. (2005) Direct involvement of the isotype-specific C-terminus of beta tubulin in ciliary beating. J Cell Sci 118:4333-41
Dumontet, Charles; Isaac, Sylvie; Souquet, Pierre-Jean et al. (2005) Expression of class III beta tubulin in non-small cell lung cancer is correlated with resistance to taxane chemotherapy. Bull Cancer 92:E25-30
Gupta, Suvroma; Banerjee, Mithu; Poddar, Asim et al. (2005) Biphasic kinetics of the colchicine-tubulin interaction: role of amino acids surrounding the A ring of bound colchicine molecule. Biochemistry 44:10181-8
Yeh, I-Tien; Luduena, Richard F (2004) The betaII isotype of tubulin is present in the cell nuclei of a variety of cancers. Cell Motil Cytoskeleton 57:96-106
Walss-Bass, Consuelo; Kreisberg, Jeffrey I; Luduena, Richard F (2003) Effect of the antitumor drug vinblastine on nuclear betaII-tubulin in cultured rat kidney mesangial cells. Invest New Drugs 21:15-20
Jensen-Smith, Heather C; Eley, Jonquille; Steyger, Peter S et al. (2003) Cell type-specific reduction of beta tubulin isotypes synthesized in the developing gerbil organ of Corti. J Neurocytol 32:185-97
Perry, Brian; Jensen-Smith, Heather C; Luduena, Richard F et al. (2003) Selective expression of beta tubulin isotypes in gerbil vestibular sensory epithelia and neurons. J Assoc Res Otolaryngol 4:329-38
Jensen-Smith, Heather C; Luduena, Richard F; Hallworth, Richard (2003) Requirement for the betaI and betaIV tubulin isotypes in mammalian cilia. Cell Motil Cytoskeleton 55:213-20
Khan, Israr A; Luduena, Richard F (2003) Different effects of vinblastine on the polymerization of isotypically purified tubulins from bovine brain. Invest New Drugs 21:3-13
Xu, Keliang; Luduena, Richard F (2002) Characterization of nuclear betaII-tubulin in tumor cells: a possible novel target for taxol. Cell Motil Cytoskeleton 53:39-52

Showing the most recent 10 out of 67 publications